Repeat Raises $6 Million in Series A Financing to Help CPG Brands Turn One-Time Buyers Into Repeat Customers
Laxman Pai, Opalesque Asia: The global investment firm KKR has raised $2.2bn for its second value-add and opportunistic European real estate fund. The fund focuses on value-added and opportunistic real estate investment...Article Link
Laxman Pai, Opalesque Asia: Amid double-digit returns and increasing assets under management, hedge fund managers have grown even more optimistic about their business prospects over the next 12 months. According to the ...Article Link
Bain Capital Ventures and Thrive Capital have co-led a DKK 940m (€126m) series-C round for Danish fintech company Pleo.
Bridgepoint has invested in PharmaReview, a life sciences compliance and copy review company.
Appian Capital, a private equity firm focused on the mining sector, is starting preparations for a potential third fund later this year, founder and CEO Michael Scherb has told Unquote.
HIG Capital has sold Germany-based window and door producer Weru to Danish market peer Dovista.
Aberdeen Standard Investments (ASI) has held a final close for its fourth private equity secondaries fund, Aberdeen Standard Secondary Opportunities Fund IV (SOF IV) on $556m, exceeding its target of $500m.
Bridgepoint has confirmed that it intends to list on the London Stock Exchange, one week after announcing its expectation to float.
A growing number of firms are investing in companies that contribute to what they call the circular economy
Rising secondary deal volume in recent years has prompted more asset managers and financial institutions to set up their own secondary advisory teams
Globally, the value of deals was $939.49bn this year to 17 June, compared with $247.65bn in the same period last year.
Access Capital Partners (ACP) has held a final close for Access Capital Fund VIII Growth Buy-out Europe (ACF VIII) on €814m.
Following three exits in 2021 so far, ESG-focused private equity firm Summa Equity's managing director Reynir Indahl discusses the effect of the pandemic on its portfolio, plans for buy-and-build, and the need for GPs to
